Chazan B - Search Results

1

Increasing Antimicrobial Resistance in Long-Term Care Facility Patients With Bacteremia: A 5 Year's Surveillance.

Almog M, Yanovskay A, Edelstein H, Schwartz N, Colodner R, Chazan B. Almog M, et al. Among authors: chazan b. J Am Med Dir Assoc. 2018 Nov;19(11):1024-1026.e1. doi: 10.1016/j.jamda.2018.06.015. Epub 2018 Aug 16. J Am Med Dir Assoc. 2018. PMID: 30122324 No abstract available.

2

Antimicrobial susceptibility of community-acquired uropathogens in northern Israel.

Colodner R, Keness Y, Chazan B, Raz R. Colodner R, et al. Among authors: chazan b. Int J Antimicrob Agents. 2001 Aug;18(2):189-92. doi: 10.1016/s0924-8579(01)00368-5. Int J Antimicrob Agents. 2001. PMID: 11516944

3

Unusual portal of entry of Vibrio vulnificus: evidence of its prolonged survival on the skin.

Colodner R, Chazan B, Kopelowitz J, Keness Y, Raz R. Colodner R, et al. Among authors: chazan b. Clin Infect Dis. 2002 Mar 1;34(5):714-5. doi: 10.1086/338871. Epub 2002 Jan 23. Clin Infect Dis. 2002. PMID: 11807684

4

Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.

Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W; Israeli Urinary Tract Infection Group. Raz R, et al. Among authors: chazan b. Clin Infect Dis. 2002 May 1;34(9):1165-9. doi: 10.1086/339812. Epub 2002 Apr 4. Clin Infect Dis. 2002. PMID: 11941541

5

Clinical predictors of streptococcal pharyngitis in adults.

Chazan B, Shaabi M, Bishara E, Colodner R, Raz R. Chazan B, et al. Isr Med Assoc J. 2003 Jun;5(6):413-5. Isr Med Assoc J. 2003. PMID: 12841012 Free article.

6

Long-term follow-up of women hospitalized for acute pyelonephritis.

Raz R, Sakran W, Chazan B, Colodner R, Kunin C. Raz R, et al. Among authors: chazan b. Clin Infect Dis. 2003 Oct 15;37(8):1014-20. doi: 10.1086/377737. Epub 2003 Sep 23. Clin Infect Dis. 2003. PMID: 14523764

7

Vaginal colonization by orally administered Lactobacillus rhamnosus GG.

Colodner R, Edelstein H, Chazan B, Raz R. Colodner R, et al. Among authors: chazan b. Isr Med Assoc J. 2003 Nov;5(11):767-9. Isr Med Assoc J. 2003. PMID: 14650098 Free article. Clinical Trial.

8

Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. Colodner R, et al. Among authors: chazan b. Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):163-7. doi: 10.1007/s10096-003-1084-2. Epub 2004 Feb 19. Eur J Clin Microbiol Infect Dis. 2004. PMID: 14986159

9

Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.

Sakran W, Raz R, Chazan B, Koren A, Colodner R. Sakran W, et al. Among authors: chazan b. Int J Antimicrob Agents. 2004 May;23(5):517-9. doi: 10.1016/j.ijantimicag.2003.09.025. Int J Antimicrob Agents. 2004. PMID: 15120735

10

Improved antimicrobial susceptibility of community-acquired uropathogens in northern Israel (1995-1999-2002).

Chazan B, Sakran W, Raz R, Colodner R. Chazan B, et al. Int J Antimicrob Agents. 2004 Jul;24(1):89-92. doi: 10.1016/j.ijantimicag.2004.01.007. Int J Antimicrob Agents. 2004. PMID: 15225869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters